Idera Pharmaceuticals, Inc. (IDRA) to Present at the 2012 Biotechnology Industry Organization (BIO) International Convention  
6/15/2012 10:18:46 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, (NASDAQ: IDRA) a biotechnology company developing novel therapeutics for autoimmune diseases and vaccine adjuvants, today announced that members of the management team will be presenting at the 2012 BIO International Convention at the Boston Convention and Exhibition Center in Boston, MA. The presentation will be made during the BIO Business forum EST in the Celtics Room (104C) on Wednesday, on June 20th, 2012 at 10:30am.